Thanks to some recent acquisitions and new partners, the company enjoyed a boost in its sales.
CannaRoyalty reported earnings of C$0.18 per share and an earnings before interest, tax, depreciation and amortization (EBITDA) of C$10.4 million.
During a conference call to discuss the results Marc Lustig, CannaRoyalty’s CEO, called Q2 an inflection point for the company, highlighting its revenue increases.
François Perrault, chief financial officer for the company, said the results for the quarter were record setting for the operator. He highlighted the C$3.5 million in revenue the company generated in the quarter surpassed the C$3 million generated during the entire fiscal 2017.
The second quarter revenue also represents a 446 percent increase from its Q1 2017 of C$643,437.
Perrault credited this revenue spike to the integration of Kaya Management and Alta Supply acquisitions for a full quarter, which he said are performing above expectations.
Despite having not closed its acquisition of River Distribution, the executives confirmed products are already running through this new partner – a move which boosted the financials for the company during this past quarter, according to Perrault.
CannaRoyalty expects to close the acquisition at a “later date in fiscal 2018,” according to company documents.
Afzal Hasan, president and general counsel of the company, told the Investing News Network (INN) the plan is to merge Alta Supply and River once the acquisition for the latter is complete.
“The really compelling part to us just like it is in California is where the consumers are and where the purchasing power is,” Hasan said when explaining the company’s strategy.
California tax revenue makes operator examine market potential
The California Department of Tax and Fee Administration (CDTFA) announced in May the state had secured US$60.9 million in tax revenue for legal cannabis sales in Q1 2018. This result caused the the Legislative Analyst’s Office for the state to drop its projections on tax revenue for the entire year.
This dip has been credited mostly to the challenges legal consumers face when buying product, instead opting for a thriving illicit market in the state.
When asked the impact these initial results in California had on CannaRoyalty operations, Hasan told INN he viewed the continued relevance of the black market as a potential for future growth.
“On the one hand we’re extremely happy in a lot of different ways about how this market has gone and that’s great, at the same time the market isn’t as big as anyone would like it to be,” Hasan said.
The executive said it was frustrating to know there are unlicensed cannabis companies in the state, avoiding payments needed to be compliant there. However, he said it’s up to the legal players and local governments to convince consumers to drop the illegal options available to them.
“There’s two methods governments can and will use to curve the illegal market, there’s sticks and carrots… The carrots are actually up to us as businesses to offer to consumers, to make products that are more compelling, more safe, more reliable and more reputable than anything else that they can find,” Hasan said.
Despite CannaRoyalty’s promising results in the long-term, Thursday’s market session wasn’t so favorable for the company’s stock. At the closing on Thursday, CannaRoyalty finished with a 1.35 percent drop to C$5.10 per share.
The company still holds a “Buy” rating from Canaccord Genuity analyst Matt Bottomley. The expert gave the company a C$8 price target.
Don’t forget to look for our coverage of MJBizCon INT’L, with show notes from the floor and exclusive interviews on INN. You can also follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).